The historic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader sector now presents questions about future gains. Alternative versions are undercutting exclusivity , prompting concerns that supporting companies heavily reliant to Viagra's once-dominant position could be a problematic move